
News · US
Trump says all 50 states will join Medicaid drug model
Health careThe administration says the GENEROUS model will cut Medicaid prescription drug costs, but the pricing agreements remain private.
News · Health care · National (US)
Falling ACA marketplace enrollment and plans to cancel coverage for nearly 760,000 people are bringing cost and eligibility questions into focus.

Key takeaways
Health care has moved to the center of political debate as millions of Americans face rising costs. Enrollment in the insurance marketplaces created by the Affordable Care Act fell this year, driven mainly by the expiration of federal credits.
Those credits had reduced the amount people paid for marketplace plans. After they expired, households faced a different cost when deciding whether to enroll or renew coverage.
Vice President Vance also announced plans to cancel coverage for nearly 760,000 people. He cited claims of widespread fraud as the reason. The announcement raises a separate question from affordability: whether people who are currently covered will remain eligible and what process will be used to end their coverage.
PBS’s Geoff Bennett discussed the developments with Larry Levitt of KFF. The health care debate now has two immediate dimensions: what insurance costs and who retains coverage.
The marketplace enrollment decline shows how changes in federal financial assistance can affect participation. The planned cancellations place fraud claims and individual coverage decisions within the same broader debate, though Vance’s stated reason does not establish the circumstances of individual cases.
The next policy questions are concrete: whether federal credits are restored, how marketplace enrollment changes and how the planned coverage cancellations are carried out. Those decisions can affect household expenses and access to insurance as voters assess health care policy before the midterms.
What to watch
Was this useful?

News · US
The administration says the GENEROUS model will cut Medicaid prescription drug costs, but the pricing agreements remain private.

News · US
The White House chief of staff underwent a procedure related to her breast cancer diagnosis and returned to work soon afterward.

News · US
The White House chief of staff said Mayo Clinic pathology results came back clear six months after her early-stage breast cancer diagnosis.

News · US
The White House chief of staff said biopsy results were clear following a medical procedure at the Mayo Clinic.